| Type 2 Diabetes Mellitus |
1 |
1 |
| Proton Pump Inhibitor |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.98 |
| Heart Failure (HF) |
0 |
0.42 |
| Coronary Artery Disease (CAD) |
0 |
0.29 |
| Cardiovascular disease |
0 |
0.17 |
| Gastroesophageal Reflux Disease |
0 |
0.13 |
| Artery |
0 |
0.08 |
| Heart |
0 |
0.08 |
| UK Site Content |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.07 |
| Microbiome |
0 |
0.07 |
| Acid Related Disorder |
0 |
0.04 |
| Antiplatelet Agent |
0 |
0.04 |
| Endocrinology |
0 |
0.04 |
| Histamine |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Prophylaxis |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Residency |
0 |
0.04 |
| Stomach |
0 |
0.04 |
| Stress |
0 |
0.04 |